-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Rapid Therapeutic Science Laboratories, Inc. quarterly/annual Revenues history and growth rate from Q2 2017 to Q2 2023.
- Rapid Therapeutic Science Laboratories, Inc. Revenues for the quarter ending June 30, 2023 was $0.000.
- Rapid Therapeutic Science Laboratories, Inc. Revenues for the twelve months ending June 30, 2023 was $0.000, a 100% decline year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. annual Revenues for 2022 was $0.000, a 100% decline from 2021.
- Rapid Therapeutic Science Laboratories, Inc. annual Revenues for 2021 was $534.000, a 99.6% decline from 2020.
- Rapid Therapeutic Science Laboratories, Inc. annual Revenues for 2020 was $131K, a 1332% increase from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)